Management of Key Ocular Adverse Events in Patients Implanted with the Port Delivery System with Ranibizumab-Reference-Cited by-同舟云学术

Management of Key Ocular Adverse Events in Patients Implanted with the Port Delivery System with Ranibizumab

Published:2022-11 Issue:11 Volume:6 Page:1028-1043
ISSN:2468-6530
Container-title:Ophthalmology Retina
language:en
Short-container-title:Ophthalmology Retina

Author:

Awh Carl C.,Barteselli Giulio,Makadia Sneha,Chang Robert T.,Stewart Jay M.,Wieland Mark R.,Brassard Raymond,Callaway Natalia F.,Gune Shamika,Heatherton Pam,Malhotra Varun,Willis Jeffrey R.,Pieramici Dante J.

Funder

Merck

Novartis

Genentech

GlaxoSmithKline

Allergan

Publisher

Elsevier BV

Subject

Ophthalmology

Reference22 articles.

1. Age-related macular degeneration preferred practice pattern®;Flaxel;Ophthalmology,2020

2. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis;Flaxman;Lancet Glob Health,2017

3. Optimizing anti-VEGF treatment outcomes for patients with neovascular age-related macular degeneration;Wykoff;J Manag Care Spec Pharm,2018

4. Caregiver burden in patients receiving ranibizumab therapy for neovascular age related macular degeneration;Gohil;PLoS One,2015

5. Disease burden in the treatment of age-related macular degeneration: findings from a time-and-motion study;Prenner;Am J Ophthalmol,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic Literature Reviews Comparing the Long-Term Safety Outcomes for the Port Delivery System with Ranibizumab (PDS) Versus Other Ocular Implants;Ophthalmology and Therapy;2024-08-01

2. Interim Results of the Phase III Portal Extension Trial of the Port Delivery System with Ranibizumab in Neovascular Age-Related Macular Degeneration;Ophthalmology Retina;2024-08

3. Endophthalmitis in Eyes Treated with the Port Delivery System with Ranibizumab;Ophthalmology Retina;2024-08

4. Ranibizumab Port Delivery System in Neovascular Age-Related Macular Degeneration: Where Do We Stand? Overview of Pharmacokinetics, Clinical Results, and Future Directions;Pharmaceutics;2024-02-23

5. Modified Split-Thickness Corneal Patch Graft for Conjunctival Erosions in Patients With the Port Delivery System Implant: Surgical Technique and Long-Term Outcomes;Journal of VitreoRetinal Diseases;2023-08-11